Effect of Anti CD20 in Pemphigus Desease

NCT00213512 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Pemphigus

Interventions

DRUG: Mabthera

Sponsor

University Hospital, Rouen